Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients

Head and neck squamous cell carcinoma (HNSCC) patients are at an increased risk of developing a second primary tumor (SPT) or recurrence following curative treatment. 13-cis-retinoic acid (13-cRA) has been tested in chemoprevention clinical trials but the results have been inconclusive. We genotyped...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lee, J. Jack, Wu, Xifeng, Hildebrandt, Michelle A.T., Yang, Hushan, Khuri, Fadlo R., Kim, Edward, Gu, Jian, Ye, Yuanqing, Lotan, Reuben, Spitz, Margaret R., Hong, Waun Ki
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955084/
https://ncbi.nlm.nih.gov/pubmed/21292633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0125
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires